Company

Tolera Therapeutics Inc.

Tolera Therapeutics develops therapies intended to promote immune tolerance in autoimmune diseases.

About

Founded in 2007 and based in Kalamazoo, US, Tolera Therapeutics develops therapies focused on immune tolerance for autoimmune diseases. In September 2014, the company raised USD 0.25 million in VENTURE DEBT from Hopen Life Science Ventures, SWMF Life Science Venture Fund, L.P., and Triathlon Medical Partners.

8Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in